General Investing >> Money Manager Interviews >> August 16, 2004


DR. SELENA A. CHAISSON rejoined RCM Capital Management in 2004 as Director, Head of U.S. Healthcare. She first joined RCM in 1994 as a Healthcare Analyst. During her tenure, she was instrumental in establishing both the RCM Global Healthcare and Biotech Funds, which she also co-managed. In mid-1999, Dr. Chaisson entered the hedge fund industry as a healthcare analyst with Tiger Management, and later created the private and public healthcare teams at Amerindo Investment Advisors. In 2001, Dr. Chaisson founded Coyote Capital Management LLC, where she provided healthcare advisory services to SAC Capital Management and managed an active hedge fund thru 2003. She earned her BS in 1987 from Louisiana State University, where she graduated summa cum laude. In 1992 and 1993, respectively, She earned her MBA and MD from Stanford University. Profile
DR. ERIC SHEN joined RCM Capital Management in 2001 as an Analyst in the healthcare group, covering biotechnology. Prior to joining RCM, Dr. Shen was a Biotechnology Analyst at Robertson Stephens, where he covered product-focused biotechnology companies. Dr. Shen graduated from Yale University magna cum laude with a BA in Biology and received an MD from New York University. He trained in internal medicine and radiology at Massachusetts General Hospital and Stanford University Hospital Profile
TWST: Would you give us a brief overview of RCM Capital Management?

Dr. Chaisson: The firm is actually part of Allianz Dresdner and within

it, there are several sectors. Every sector is run by